Special Verification Report on the Company's Revenue Deduction Explanation
To: All shareholders of Shenzhen Saisheng Pharmaceutical Co., Ltd.
We have accepted the commission to conduct a special verification of the "Revenue Deduction Explanation Table" (hereinafter referred to as the "Revenue Deduction Table") prepared by Shenzhen Saisheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Saisheng Pharmaceutical") based on the audited consolidated and company balance sheets as of December 31, 2025, the consolidated and company income statements, consolidated and company cash flow statements, consolidated and company statements of changes in shareholders' equity, and the notes to the financial statements.
In accordance with the relevant provisions of the Shenzhen Stock Exchange's "Listing Rules for Growth Enterprise Market Stocks" (hereinafter referred to as the "Listing Rules") and the "Self-Regulatory Guidelines No. 1 for Growth Enterprise Market Listed Companies - Business Handling" (hereinafter referred to as the "Self-Regulatory Guidelines"), the Revenue Deduction Table has been prepared to ensure that its content is true, accurate, and complete, with no false records, misleading statements, or significant omissions. It is the responsibility of Saisheng Pharmaceutical's management, while our responsibility is to provide a verification conclusion based on the verification work conducted.